Experts Tell Congressional Briefing FDA Lets Bad Generics On Market
This article was originally published in PharmAsia News
Executive Summary
A group of physician experts and others told a U.S. Congressional briefing that many unqualified generic drugs are reaching the market despite FDA, many of them ineffective or harmful to patients.